ArticleEuropean journal of haematology2025

Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission.

Avraham Frisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.